Corrigendum to: PEGylated Albumin-Based Drug Carriers for the Treatment of Experimental Stroke

All published articles of this journal are available on ScienceDirect.

CORRIGENDUM

Corrigendum to: PEGylated Albumin-Based Drug Carriers for the Treatment of Experimental Stroke

Nazeli Zaqaryan1 Rita Khallouf1 , 2 Arpi Manukyan1 iD Vahe Atoyan1 Astghik Tsokolakyan3 iD Mkrtich A. Yeranosyan3 iD Samvel G. Chailyan1 iD Kristine E. Danielyan1 , 2 , * Open Modal iD
Authors Info & Affiliations
The Open Biotechnology Journal • 02 Feb 2026 • CORRIGENDUM • DOI: 10.2174/011874070720260120

In the online version of the article, a change was made in a reference of the article titled “PEGylated Albumin-Based Drug Carriers for the Treatment of Experimental Stroke”, which has been updated in “The Open Biochemistry Journal”, 2025; 19: e18740707379038 [1].

The original article can be found online at: https://openbiotechnologyjournal.com/VOLUME/19/ELOCATOR/e18740707379038/FULLTEXT/

Original

[19] Berman H, Henrick K, Nakamura H. Announcing the worldwide Protein Data Bank. Nat Struct Biol 2003; 10(12): 980.

https://doi.org/0.1038/nsb1203-980

Corrected

[19] Berman H, Henrick K, Nakamura H. Announcing the worldwide Protein Data Bank. Nat Struct Biol 2003; 10(12): 980.

http://dx.doi.org/10.1038/nsb1203-980

REFERENCE

1
Zaqaryan N, Khallouf R, Manukyan A, et al. PEGylated Albumin-Based Drug Carriers for the Treatment of Experimental Stroke. Open Biotechnol J 2025; 19: e18740707379038.